Associate Director, Trade Operations & Customs Processes at Moderna

Madrid, Community of Madrid, Spain

Moderna Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Bachelor's degree in Business, International Trade, Supply Chain, or related field
  • Minimum 10 years of experience

Responsibilities

  • Lead the optimization and execution of global customs processes, ensuring adherence to internal standards and evolving regulatory requirements
  • Develop, maintain, and deploy global standard operating procedures (SOPs) for import/export and customs clearance processes
  • Manage global customs brokerage performance, including implementation and monitoring of service level agreements (SLAs) and driving continuous improvements
  • Oversee global customs clearance activities, identifying and resolving delays, inconsistencies, or operational breakdowns in collaboration with regional stakeholders
  • Advance customs operations through process automation, especially in areas like classification, valuation, and origin determination
  • Act as the subject matter expert for global customs operations, supporting the Trade Compliance team and addressing complex operational issues
  • Lead digital trade compliance initiatives, particularly SAP GTS and broker integration workflows, in partnership with Digital/IT teams
  • Evaluate tariff impacts and deliver analyses to guide decisions in sourcing, supply chain, and planning while maintaining trade compliance and cost efficiency
  • Spearhead the implementation of Importer of Record (IOR) capabilities in new and existing global markets
  • Collaborate with Logistics, Supply Chain, Planning, Quality, and Finance teams to ensure customs decisions are embedded in end-to-end workflows
  • Participate in international travel as needed for operational reviews, audits, or system deployments
  • Carry out additional duties as assigned in line with strategic business needs

Skills

SAP GTS
Customs Clearance
Trade Compliance
Global Brokerage
SOP Development
SLA Management
Import Export
Supply Chain Optimization
Regulatory Compliance
Process Automation

Moderna

Develops mRNA-based medicines for health

About Moderna

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.

Cambridge, MassachusettsHeadquarters
2010Year Founded
$5,925.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Hybrid Work Options
401(k) Company Match
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend

Risks

Potential backlash in Australia for bypassing vaccine safety steps.
Possible removal from Nasdaq 100 Index could affect investor confidence.
Hong Kong residents' reluctance to get vaccinated may hinder market penetration.

Differentiation

Moderna is pioneering mRNA technology for new categories of medicines.
The company integrates AI to optimize mRNA design and production processes.
Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Upsides

Moderna received a $176 million contract for a bird flu vaccine.
The company is expanding mRNA applications to personalized cancer vaccines.
Moderna is establishing a domestic mRNA production facility in Australia.

Land your dream remote job 3x faster with AI